Robert Wasserman
Stock Analyst at Benchmark
(2.40)
# 2,394
Out of 4,883 analysts
113
Total ratings
43.93%
Success rate
-0.58%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Reiterates: Buy | $75 | $53.07 | +41.32% | 7 | Jun 5, 2025 | |
| KMDA Kamada | Reiterates: Buy | $15 | $7.82 | +91.82% | 2 | May 15, 2025 | |
| OABI OmniAb | Reiterates: Buy | $6 | $1.92 | +212.50% | 9 | May 12, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $150 → $140 | $121.19 | +15.52% | 11 | Apr 25, 2025 | |
| XOMA XOMA Royalty | Initiates: Buy | $35 | $26.68 | +31.21% | 1 | Apr 17, 2025 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Speculative Buy | $3 | $1.24 | +141.94% | 6 | Apr 1, 2025 | |
| ABCL AbCellera Biologics | Reiterates: Hold | n/a | $3.71 | - | 6 | Mar 3, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $75 | $54.14 | +38.53% | 9 | Feb 20, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $30 | $22.83 | +31.41% | 6 | Dec 19, 2024 | |
| ANEB Anebulo Pharmaceuticals | Reiterates: Speculative Buy | $8 | $1.76 | +354.55% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $4.05 | +23.46% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $6.96 | +72.41% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $2.80 | - | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $127.13 | - | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $12 | $0.30 | +3,900.00% | 6 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $41.16 | +9.34% | 6 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $4.06 | -1.37% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $0.19 | +1,960.79% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $75 | $1.90 | +3,847.37% | 2 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $202.65 | - | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $426.94 | +35.85% | 1 | Jul 16, 2021 |
Bio-Techne
Jun 5, 2025
Reiterates: Buy
Price Target: $75
Current: $53.07
Upside: +41.32%
Kamada
May 15, 2025
Reiterates: Buy
Price Target: $15
Current: $7.82
Upside: +91.82%
OmniAb
May 12, 2025
Reiterates: Buy
Price Target: $6
Current: $1.92
Upside: +212.50%
Integer Holdings
Apr 25, 2025
Maintains: Buy
Price Target: $150 → $140
Current: $121.19
Upside: +15.52%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $26.68
Upside: +31.21%
ImmunoPrecise Antibodies
Apr 1, 2025
Reiterates: Speculative Buy
Price Target: $3
Current: $1.24
Upside: +141.94%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.71
Upside: -
Halozyme Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $75
Current: $54.14
Upside: +38.53%
BioLife Solutions
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $22.83
Upside: +31.41%
Anebulo Pharmaceuticals
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $1.76
Upside: +354.55%
Nov 12, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $4.05
Upside: +23.46%
Nov 7, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $6.96
Upside: +72.41%
Nov 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $2.80
Upside: -
Aug 5, 2024
Reiterates: Hold
Price Target: n/a
Current: $127.13
Upside: -
Jul 11, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $0.30
Upside: +3,900.00%
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $41.16
Upside: +9.34%
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $4.06
Upside: -1.37%
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $0.19
Upside: +1,960.79%
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $1.90
Upside: +3,847.37%
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $202.65
Upside: -
Jul 16, 2021
Initiates: Buy
Price Target: $580
Current: $426.94
Upside: +35.85%